Nearly half of all adults in the U.S. have high blood pressure, or hypertension, according to the CDC. One of the most common ...

I first took beta blockers two years ago, when I was asked to give a eulogy. Terrible at public speaking on a good day, let alone at a funeral, my first instinct was to refuse to do it. I had made a ...

Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association's 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...

For 40 years, it has been the standard in post-heart attack health care, but a new study from the European Society of Cardiology is putting the usage of beta blockers in limbo. While the new study may ...

Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained ...

An unlikely byproduct of the Oscars red-carpet coverage last Sunday? The mention of beta blockers by actor Rachel Sennott, who told a host that her pre-event routine is to “take that beta blocker, ...

Advances in the treatment of coronary artery disease remained steady in 2025, as in recent years, but the past 12 months also ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." While lorazepam has been the talk of the town thanks to The White Lotus, there’s another med competing ...

Beta-blocker use is associated with a 34% reduction of onset in premanifest Huntington disease (preHD) and slower progression in early motor-manifest Huntington disease (mmHD), new research shows. In ...

Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter ...

Without question, there is a fair deal of negative stigma surrounding traditional psychopharmaceutical treatments for problems such as anxiety, depression, and panic. While these medications of ...

MADRID -- Beta-blockers may be relegated to a smaller role for secondary prevention after myocardial infarction (MI) in contemporary practice, based on the arrival of three new trials from Europe.